<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03564431</url>
  </required_header>
  <id_info>
    <org_study_id>841026</org_study_id>
    <nct_id>NCT03564431</nct_id>
  </id_info>
  <brief_title>The Imaging Genetic Study of Type 2 Diabetes and Depression</brief_title>
  <official_title>The Study of Structural and Functional Brain Abnormalities and the Association With the Genetic Polymorphism in the Type 2 Diabetes Patient With Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kunming Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kunming Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the structural/functional abnormalities and the possible genetic
      endophenotypes of in the Type 2 Diabetes Patient With Depression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes and depression are harmful to human health,but they often co-exist.At present, the
      pathophysiological mechanisms underlying the comorbidity of diabetes and depression are
      discussed, including hypothalamic-pituitary-adrenal axis dysfunction, inflammation,
      epigenetics, disturbed circadian rhythms, environmental and behavioral
      factors,neuroimaging,etc.the purpose of the investigator's study is to investigate the
      structural/functional abnormalities and the possible genetic endophenotypes of in the Type 2
      Diabetes Patient With Depression.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the neuroimaging of Type 2 Diabetes and Depression</measure>
    <time_frame>from 2017-12 to 2019-12</time_frame>
    <description>the structure and function of Abnormalities in the T2DM Patients</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>T2DM</condition>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>T2DM patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>depression patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>T2DM with depression patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic resonance</intervention_name>
    <description>magnetic resonance spectrum of brain</description>
    <arm_group_label>T2DM patients</arm_group_label>
    <arm_group_label>T2DM with depression patients</arm_group_label>
    <arm_group_label>controls</arm_group_label>
    <arm_group_label>depression patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      perapheral blood DNA of all participants
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        T2DM and depression patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        conform to type 2 diabetes, depression, diagnostic criteria of unrelated normal controls
        the han nationality patients; Aged 30 to 70 years of age, gender not limited; The patient
        or legal guardian have signed informed consent of patients.

        Exclusion Criteria:

        Magnetic resonance imaging has the contraindication, such as metal implants,
        claustrophobic, etc.

        With severe body diseases, including inflammatory diseases and autoimmune diseases; Current
        or past history of nervous system disease or brain injury. Merge other severe mental
        illness or existing psychotic symptoms; Always have a mania, hypomania attack; Has a
        history of substance abuse; Pregnant women and nursing mothers; Estimated compliance is
        poorer, not partners; Is being treated for a mental drug therapy, and ECT, TMS; Patients
        with a body mass index &gt; 35; There are currently no taking corticosteroids, immune
        regulator, etc. Now or ever did not suffer from patients with other diagnosis to the dsm-iv
        axis I; Merge the endocrine system disease, thyroid, adrenal gland and pituitary gland
        diseases, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiufeng Xu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Psychiatry department of KMU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li Shi, MD</last_name>
    <phone>8687165324888</phone>
    <email>shili1026@163.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Psychiatry department, The 1st Affiliated Hospital of Kunming Medical University</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <zip>650032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiufeng Xu, MD</last_name>
      <phone>8687165324888</phone>
      <email>xfxu2004@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>June 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2018</study_first_posted>
  <last_update_submitted>September 15, 2019</last_update_submitted>
  <last_update_submitted_qc>September 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kunming Medical University</investigator_affiliation>
    <investigator_full_name>Yuqi Cheng</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

